US5830686A
(en)
*
|
1994-01-13 |
1998-11-03 |
Calydon |
Tissue-specific enhancer active in prostate
|
US6057299A
(en)
*
|
1994-01-13 |
2000-05-02 |
Calydon, Inc. |
Tissue-specific enhancer active in prostate
|
US5998205A
(en)
*
|
1994-11-28 |
1999-12-07 |
Genetic Therapy, Inc. |
Vectors for tissue-specific replication
|
US6638762B1
(en)
*
|
1994-11-28 |
2003-10-28 |
Genetic Therapy, Inc. |
Tissue-vectors specific replication and gene expression
|
DE69638058D1
(de)
|
1995-06-15 |
2009-11-26 |
Crucell Holland Bv |
Verpackungssysteme für humane rekombinante Adenoviren zur Gentherapie
|
FR2735789B1
(fr)
*
|
1995-06-23 |
1997-07-25 |
Centre Nat Rech Scient |
Adenovirus recombinants, leur utilisation pour preparer des aav, lignee cellulaire complementaire et compositions pharmaceutiques les contenant
|
US20020068049A1
(en)
*
|
1998-09-10 |
2002-06-06 |
Henderson Daniel R. |
Tissue specific adenoviral vectors
|
US6254862B1
(en)
|
1997-03-03 |
2001-07-03 |
Calydon, Inc. |
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
|
US6197293B1
(en)
*
|
1997-03-03 |
2001-03-06 |
Calydon, Inc. |
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
|
US7011976B1
(en)
|
1997-03-03 |
2006-03-14 |
Calydon, Inc. |
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
|
US7001764B2
(en)
*
|
1995-06-27 |
2006-02-21 |
Cell Genesys, Inc. |
Compositions comprising tissue specific adenoviral vectors
|
US6676935B2
(en)
*
|
1995-06-27 |
2004-01-13 |
Cell Genesys, Inc. |
Tissue specific adenoviral vectors
|
US6110702A
(en)
*
|
1996-03-27 |
2000-08-29 |
The Regents Of The University Of California |
PSA positive regulating (PSAR) sequences and uses thereof
|
AUPO023496A0
(en)
*
|
1996-05-31 |
1996-06-27 |
Commonwealth Scientific And Industrial Research Organisation |
Modified small RNA viruses
|
US6610839B1
(en)
|
1997-08-14 |
2003-08-26 |
Geron Corporation |
Promoter for telomerase reverse transcriptase
|
US5772993A
(en)
*
|
1997-01-21 |
1998-06-30 |
The University Of Virginia Patent Foundation |
Osteocalcin promoter-based toxic gene therapy for the treatment of calcified tumors and tissues
|
US6403370B1
(en)
*
|
1997-02-10 |
2002-06-11 |
Genstar Therapeutics Corporation |
Oncolytic/immunogenic complementary-adenoviral vector system
|
US6100444A
(en)
*
|
1997-02-11 |
2000-08-08 |
University Of Rochester Medical Center |
Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen
|
EP1905837A1
(de)
*
|
1997-03-03 |
2008-04-02 |
Cell Genesys, Inc. |
Adenovirusvektoren mit heterologen Transkriptionsregulationselementen und diese verwendende Verfahren
|
US6432700B1
(en)
*
|
1997-03-03 |
2002-08-13 |
Cell Genesys, Inc. |
Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
|
AU744725B2
(en)
*
|
1997-03-03 |
2002-02-28 |
Cold Genesys, Inc. |
Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
|
WO1998039467A2
(en)
*
|
1997-03-03 |
1998-09-11 |
Calydon, Inc. |
Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
|
IL120485A0
(en)
*
|
1997-03-19 |
1997-07-13 |
Yeda Res & Dev |
Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
|
JP4812914B2
(ja)
*
|
1997-06-23 |
2011-11-09 |
ユニバーシティ オブ サスカチュワン |
ウシアデノウイルスタイプ3ゲノム
|
ATE376062T1
(de)
|
1997-08-04 |
2007-11-15 |
Cell Genesys Inc |
Enhancer des menschlichen glandulären kallikreingens, vektoren die ihn enthalten und methoden für seine verwendung
|
US6716823B1
(en)
|
1997-08-13 |
2004-04-06 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
US20030045492A1
(en)
*
|
1997-08-13 |
2003-03-06 |
Tang De-Chu C. |
Vaccination by topical application of recombinant vectors
|
US20030125278A1
(en)
*
|
1997-08-13 |
2003-07-03 |
Tang De-Chu C. |
Immunization of animals by topical applications of a salmonella-based vector
|
US6348450B1
(en)
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
US6706693B1
(en)
|
1997-08-13 |
2004-03-16 |
The Uab Research Foundation |
Vaccination by topical application of genetic vectors
|
EP1015003A1
(de)
*
|
1997-09-19 |
2000-07-05 |
Johnson & Johnson Research Pty Ltd. |
Transgene autologe t-zelltherapie bei menschen, und verwandte zusammensetzungen und kits
|
US7378244B2
(en)
*
|
1997-10-01 |
2008-05-27 |
Geron Corporation |
Telomerase promoters sequences for screening telomerase modulators
|
US20030044384A1
(en)
*
|
1997-10-09 |
2003-03-06 |
Pro-Virus, Inc. |
Treatment of neoplasms with viruses
|
US7470426B1
(en)
*
|
1997-10-09 |
2008-12-30 |
Wellstat Biologics Corporation |
Treatment of neoplasms with viruses
|
US7780962B2
(en)
*
|
1997-10-09 |
2010-08-24 |
Wellstat Biologics Corporation |
Treatment of neoplasms with RNA viruses
|
WO1999043697A1
(en)
*
|
1998-02-25 |
1999-09-02 |
The Board Of Regents Of The University And Community College System Of Nevada On Behalf Of The University Of Nevada-Reno |
Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
|
US6395473B1
(en)
*
|
1998-07-14 |
2002-05-28 |
Merck & Co., Inc. |
Adenoviral based promoter assay
|
US6900049B2
(en)
|
1998-09-10 |
2005-05-31 |
Cell Genesys, Inc. |
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
|
US7691370B2
(en)
*
|
1998-10-15 |
2010-04-06 |
Canji, Inc. |
Selectivity replicating viral vector
|
US6929946B1
(en)
*
|
1998-11-20 |
2005-08-16 |
Crucell Holland B.V. |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
|
US6495130B1
(en)
|
1998-12-30 |
2002-12-17 |
Calydon, Inc. |
Target cell-specific adenoviral vectors containing E3 and methods of use thereof
|
US20060024273A1
(en)
*
|
1998-12-30 |
2006-02-02 |
Henderson Daniel R |
Target cell-specific adenoviral vectors containing E3 and methods of use thereof
|
HUP0302278A3
(en)
*
|
1999-04-15 |
2011-01-28 |
Pro Virus |
Treatment of neoplasms with viruses
|
US20040009936A1
(en)
*
|
1999-05-03 |
2004-01-15 |
Tang De-Chu C. |
Vaccine and drug delivery by topical application of vectors and vector extracts
|
US6913922B1
(en)
*
|
1999-05-18 |
2005-07-05 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
WO2000074688A1
(en)
*
|
1999-06-08 |
2000-12-14 |
The Children's Hospital Of Philadelphia |
Methods for preventing formation of inhibitory antibodies in the setting of gene therapy
|
DE19928342A1
(de)
*
|
1999-06-21 |
2000-12-28 |
Deutsches Krebsforsch |
Vektoren zur gentherapeutischen Tumorbehandlung
|
US8147822B1
(en)
|
1999-09-17 |
2012-04-03 |
Wellstat Biologics Corporation |
Oncolytic virus
|
WO2001027256A2
(en)
|
1999-10-14 |
2001-04-19 |
The Regents Of The University Of California System |
Chimeric transcriptional regulatory element and methods for prostate-targeted gene expression
|
ATE419338T1
(de)
|
2000-03-24 |
2009-01-15 |
Cell Genesys Inc |
Menschliche zellspezifische urotheliale regulatorische sequenzen der transkription des uroplakins, dessen vektoren und verwendungsverfahren
|
US20030212022A1
(en)
*
|
2001-03-23 |
2003-11-13 |
Jean-Marie Vogel |
Compositions and methods for gene therapy
|
ES2551164T3
(es)
|
2000-03-24 |
2015-11-16 |
Biosphere Medical, Inc. |
Microesferas para embolización activa
|
US6911200B2
(en)
*
|
2000-03-24 |
2005-06-28 |
Cell Genesys, Inc. |
Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation
|
US7048920B2
(en)
*
|
2000-03-24 |
2006-05-23 |
Cell Genesys, Inc. |
Recombinant oncolytic adenovirus for human melanoma
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
US6896885B2
(en)
*
|
2000-03-31 |
2005-05-24 |
Biogen Idec Inc. |
Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma
|
US20040101825A1
(en)
*
|
2001-09-26 |
2004-05-27 |
Van Meir Erwin G. |
Viruses targeted to hypoxic cells and tissues
|
US7285414B2
(en)
*
|
2000-09-26 |
2007-10-23 |
Emory University |
Viruses targeted to hypoxic cells and tissues
|
EP1207205A1
(de)
*
|
2000-11-20 |
2002-05-22 |
Crucell Holland B.V. |
Adenovirale Replikone
|
AU2002235141A1
(en)
|
2000-11-27 |
2002-06-03 |
Geron Corporation |
Glycosyltransferase vectors for treating cancer
|
WO2002053711A2
(de)
*
|
2000-12-28 |
2002-07-11 |
Per Sonne Holm |
Verwendung des transkriptionsfaktors yb-1 in adenoviralen systemen
|
EP1425413A2
(de)
*
|
2001-01-23 |
2004-06-09 |
Irm, Llc |
Gene überexprimiert in prostataerkrankungen als diagnose- und therapeutische ziele
|
EP1377672A2
(de)
*
|
2001-02-23 |
2004-01-07 |
Novartis AG |
Vektorkonstrukte
|
US20030021768A1
(en)
*
|
2001-07-23 |
2003-01-30 |
Yuqiao Shen |
Viral mutants that selectively replicate in targeted human cancer cells
|
US20030099616A1
(en)
*
|
2001-07-25 |
2003-05-29 |
Irving John M. |
Dual specificity tumor killing vectors driven by the telomerase promoter
|
JP2005517394A
(ja)
|
2001-12-12 |
2005-06-16 |
エフ エイチ フォールディング アンド カンパニー リミテッド |
ウイルス保存のための組成物
|
JP4495587B2
(ja)
*
|
2002-04-25 |
2010-07-07 |
クルセル ホランド ベー ヴェー |
組換えアデノウイルスベクターおよびその使用
|
KR101083450B1
(ko)
|
2002-05-27 |
2011-11-16 |
페르 손네 홀름 |
아데노바이러스 및 그를 코딩하는 핵산의 신규 용도
|
US7364727B2
(en)
*
|
2002-07-22 |
2008-04-29 |
Cell Genesys, Inc. |
Metastatic colon cancer specific promoter and uses thereof
|
US7977049B2
(en)
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
CA2421269A1
(en)
|
2002-08-09 |
2004-02-09 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
US20050095705A1
(en)
*
|
2003-04-15 |
2005-05-05 |
Michael Kadan |
Method for production of oncolytic adenoviruses
|
US20050136035A1
(en)
*
|
2003-06-03 |
2005-06-23 |
Derek Ko |
Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
|
EP1636360A4
(de)
*
|
2003-06-03 |
2006-11-08 |
Cell Genesys Inc |
Zusammensetzungen und verfahren zur verstärkten expression rekombinanter polypeptide von einem vektor unter verwendung einer peptidspaltstelle
|
US20050079158A1
(en)
*
|
2003-06-05 |
2005-04-14 |
Shenzhen Allucks Biotech Co., Ltd. |
Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof
|
ATE500267T1
(de)
|
2003-07-21 |
2011-03-15 |
Transgene Sa |
Multifunktionelle cytokine
|
US20050186178A1
(en)
*
|
2003-08-28 |
2005-08-25 |
Ennist David L. |
Oncolytic adenoviral vectors encoding GM-CSF
|
US7482156B2
(en)
*
|
2003-10-15 |
2009-01-27 |
Cell Genesys, Inc. |
Hepatocellular carcinoma specific promoter and uses thereof
|
CA2546178A1
(en)
|
2003-11-14 |
2005-06-09 |
Per Sonne Holm |
New use of adenovirus and nucleic acids coding therefor
|
US7473418B2
(en)
*
|
2004-03-25 |
2009-01-06 |
Cell Genesys, Inc. |
Pan cancer oncolytic vectors and methods of use thereof
|
US20050271622A1
(en)
*
|
2004-06-03 |
2005-12-08 |
Shenzhen Allucks Biotech Co., Ltd. |
Construct of tumor-selective recombinant adenovirus, method for preparing the same and use thereof
|
GB0416487D0
(en)
*
|
2004-07-23 |
2004-08-25 |
Isis Innovation |
Modified virus
|
NZ553224A
(en)
*
|
2004-07-26 |
2009-05-31 |
Asterion Ltd |
Linkers
|
US20060062764A1
(en)
*
|
2004-08-25 |
2006-03-23 |
Seshidar-Reddy Police |
Fiber-modified adenoviral vectors for enhanced transduction of tumor cells
|
AU2006216671A1
(en)
|
2005-02-23 |
2006-08-31 |
The Uab Research Foundation |
Alkyl-glycoside enhanced vaccination
|
US20060205080A1
(en)
*
|
2005-03-01 |
2006-09-14 |
David Frey |
Formulations for therapeutic viruses having enhanced storage stability
|
KR20140090270A
(ko)
|
2005-05-09 |
2014-07-16 |
바이오스피어 메디칼 에스.에이. |
마이크로스피어 및 비이온성 조영제를 사용하는 조성물 및 방법
|
WO2008092854A2
(en)
|
2007-01-30 |
2008-08-07 |
Transgene S.A. |
Papillomavirus e2 polypeptide used for vaccination
|
DK2382474T3
(en)
|
2009-01-20 |
2015-04-07 |
Transgene Sa |
SOLUBLE ICAM-1 as a biomarker FOR PREDICTION OF THERAPEUTIC RESPONSE
|
JP6342115B2
(ja)
|
2009-03-20 |
2018-06-13 |
メゾブラスト,インコーポレーテッド |
再プログラム化多能性細胞の作製
|
EP2411815B1
(de)
|
2009-03-24 |
2015-11-11 |
Transgene SA |
Biomarker zum monitoring von patienten
|
BRPI1010512A2
(pt)
|
2009-04-17 |
2016-03-15 |
Transgène S A |
"método ex vivo para avaliar a eficácia de um tratamento envolvendo a administração de uma composição imunogênica a um paciente, e, uso de níveis de linfócitos t ativados (cd3 + cd69+) como um biomarcador"
|
AU2010270313B2
(en)
|
2009-07-10 |
2014-05-22 |
Transgene Sa |
Biomarker for selecting patients and related methods
|
GB0919773D0
(en)
|
2009-11-12 |
2009-12-30 |
Univ Nottingham |
Induced pluripotent stem cell
|
CN101899420A
(zh)
*
|
2010-01-16 |
2010-12-01 |
韩从辉 |
一种靶向抗前列腺肿瘤的表达超抗原基因的双调控溶瘤腺病毒的制备方法
|
CA2807440A1
(en)
|
2010-08-04 |
2012-02-09 |
Cizzle Biotechnology Limited |
Methods and compounds for the diagnosis and treatment of cancer
|
GB201016852D0
(en)
|
2010-10-07 |
2010-11-17 |
Univ York |
Cell differentiation
|
GB201102090D0
(en)
|
2011-02-08 |
2011-03-23 |
Univ Sheffield |
Antigenic polypeptide
|
GB201102091D0
(en)
|
2011-02-08 |
2011-03-23 |
Univ Sheffield |
Antigenic polypeptide
|
WO2014066443A1
(en)
|
2012-10-23 |
2014-05-01 |
Emory University |
Gm-csf and il-4 conjugates, compositions, and methods related thereto
|
EP3684421A4
(de)
|
2017-09-18 |
2021-08-04 |
Children's Hospital Medical Center |
Starker isolator und seine verwendung im gentransfer
|
US20200405829A1
(en)
|
2019-06-28 |
2020-12-31 |
Massachusetts Institute Of Technology |
Circular strained zymogen compositions and methods of use
|
MX2022008772A
(es)
|
2020-01-14 |
2022-10-07 |
Synthekine Inc |
Ortologos de il2 y metodos de uso.
|